Detection of bacillus Calmette-Guerin in the blood by the polymerase chain reaction method of treated bladder cancer patients

Journal of Urology

Volumn 158, Issue 6, 1997, Pages 2109-2112

  Tuncer, Serdar ^a   Tekin, Mehmet Ilteriş ^a   Özen, Haluk ^a   Bilen, Cenk ^a   Ünal, Serhat ^a   Remzi, Doǧan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

BCG vaccine; Bladder neoplasms; Polymerase chain reaction

Indexed keywords

BACTERIAL DNA; BCG VACCINE;

ADULT; AGED; ARTICLE; BACTEREMIA; BLADDER CANCER; BLADDER SURGERY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DYSURIA; FEMALE; HEMATURIA; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0030729395     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)68169-2     Document Type: Article

References (15)

1. Lamm, A. L., van der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A. and Debruyne, F. M. J.: Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J. Urol., 147: 596, 1992.
2. Brosman, S. A.: Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma. J. Urol., 128: 27, 1982.
3. Steg, A., Lelue, C., Debre, B., Boccon-Gibod, L. and Sicard, D.: Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. In: EORTC Genitourinary Group Monograph 6: BCG in Superficial Bladder Cancer. Edited by F. M. J. Debruyne, L. Denis and A. P. M. van der Meijden. New York: Alan R. Liss, Inc., pp. 325-334, 1989.
4. Eisenach, K. D., Cave, M. D., Bates, J. H. and Crawford, J. T.: Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J. Infect. Dis., 161: 977, 1990.
5. Zbar, B., Bernstein, I. D. and Rapp, H. J.: Suppression of tumor growth at the side of infection with living bacillus Calmette-Guerin. J. Natl. Cancer Inst., 46: 831, 1971.
6. Flippin, T., Mukherji, B. and Dayal, Y.: Granulomatous hepatitis as a late complication of BCG immunotherapy. Cancer, 46: 1759, 1980.
7. DeJong, W. H., De Boer, E. C., Van der Meijden, A. P. M., Vegt, P., Steerenberg, P. A., Debruyne, F. M. J. and Ruitenberg, E. J.: Presence of interleukin 2 in urine of superficial bladder cancer patients after intravesical treatment with Bacillus Calmette-Guerin. Cancer Immunol. Immunother., 31: 182, 1990.
8. Ratliff, T. L.: Mechanisms of action of intravesical BCG for bladder cancer. In: BCG in Superficial Bladder Cancer. Edited by F. M. J. Debruyne, L. Denis and A. P. M. van der Meijden. New York: Alan R. Liss, Inc., pp. 325-334, 1989.
9. Balbay, D., Özen, H., Özkardeş, H., Barut, A., Bakkaloglu, M., Tasar, C. and Remzi, D.: Detection of urinary interleukin-2, interleukin-2 receptor and tumor necrosis factor levels in patients with superficial bladder tumors after intravesical BCG immunotherapy. Urology, 43: 187, 1994.
10. Pinsky, C. M., Hirhault, Y. and Oettgen, H.: Treatment of malignant melanoma by intra-tumoral injection of BCG. Natl. Cancer Inst. Monogr., 39: 225, 1973.
11. Civen, R., Berlin, G. and Panosian, C.: Vertabral osteomyelitis after intravesical administration of Bacille Calmette-Guerin. Clin. Infect. Dis., 18: 1013, 1994.
12. Folgueira, L., Delgado, R., Palenque, E., Aguado, J. M. and Noriega, A. R.: Rapid diagnosis of Mycobacterium tuberculosis bacteremia by PCR. J. Clin. Microbiol., 34: 512, 1996.
13. Schluger, N. W., Condos, R., Lewis, S. and Rom, W. N.: Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet, 344: 232, 1994.
14. Iralu, J. V., Sritharan, V. K., Pieciak, W. S., Wirth, D. F., Maguire, J. H. and Barker, R. H.: Diagnosis of Mycobacterium avium Bacteremia by polymerase chain reaction. J. Clin. Microbiol., 31: 1811, 1993.
15. Lamm, D. L., Stogdill, V. D., Stogdill, B. J. and Crispen, R. G.: Complications of bacillus Calmette-Guerin immumotherapy in 1278 patients with bladder cancer. J. Urol., 135: 272, 1986.